Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Saved in:
| Title: | Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. |
|---|---|
| Authors: | Sokolenko, Anna P.1,2 (AUTHOR) annasokolenko@mail.ru, Gorodnova, Tatiana V.3 (AUTHOR), Bizin, Ilya V.1 (AUTHOR), Kuligina, Ekaterina Sh.1 (AUTHOR), Kotiv, Khristina B.3 (AUTHOR), Romanko, Alexandr A.1 (AUTHOR), Ermachenkova, Tatiana I.1 (AUTHOR), Ivantsov, Alexandr O.1 (AUTHOR), Preobrazhenskaya, Elena V.1 (AUTHOR), Sokolova, Tatiana N.1 (AUTHOR), Broyde, Robert V.4 (AUTHOR), Imyanitov, Evgeny N.1,2,5 (AUTHOR) |
| Source: | Cancer Chemotherapy & Pharmacology. Sep2021, Vol. 88 Issue 3, p439-450. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
